Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss

OBJECTIVE: To explore the effects of anti-tumour necrosis factor (TNF)α antibody therapy on bone mineral density (BMD) of the lumbar spine and femur neck in patients with rheumatoid arthritis (RA). METHODS: A total of 50 patients with active RA (DAS28⩾3.2) who started adalimumab (40 mg subcutaneousl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wijbrandts, C A, Klaasen, R, Dijkgraaf, M G W, Gerlag, D M, van Eck-Smit, B L F, Tak, P P
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2945478/
https://ncbi.nlm.nih.gov/pubmed/18408246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2008.091611
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares